October 30, 2017 / 1:02 AM / 4 months ago

Fosun Pharma to buy France's Tridem for $73 million

HONG KONG (Reuters) - Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196.SS) (2196.HK) said it would buy French drug distributor Tridem Pharma S.A.S. for 63 million euros ($73 million), in a move to expand its market share in Europe and Africa.

    The Chinese drug maker said in a statement that it will buy shares in Tridem from major shareholders including Financière des Lices, Multicroissance, and a French fund FCPR PMC II.

    Tridem has a sales network covering 21 French-speaking African countries and regions.

    This month, Fosun Pharma bought 74 percent of India’s Gland Pharma for around $1.1 billion.

    Reporting by Donny Kwok; Editing by Edwina Gibbs

    0 : 0
    • narrow-browser-and-phone
    • medium-browser-and-portrait-tablet
    • landscape-tablet
    • medium-wide-browser
    • wide-browser-and-larger
    • medium-browser-and-landscape-tablet
    • medium-wide-browser-and-larger
    • above-phone
    • portrait-tablet-and-above
    • above-portrait-tablet
    • landscape-tablet-and-above
    • landscape-tablet-and-medium-wide-browser
    • portrait-tablet-and-below
    • landscape-tablet-and-below